H.C. Wainwright Downgrades Kazia Therapeutics (KZIA) to Neutral
Tweet
Share
E-mailGet Alerts KZIA Hot Sheet
Price: $12.97 -1.82%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Sean Lee downgraded Kazia Therapeutics (NASDAQ: KZIA) from Buy to Neutral.
For an analyst ratings summary and ratings history on Kazia Therapeutics click here. For more ratings news on Kazia Therapeutics click here.
Shares of Kazia Therapeutics closed at $1.92 yesterday.
You May Also Be Interested In
- Canaccord Starts Kazia Therapeutics (KZIA) at Buy
- RBC Capital Downgrades CareTrust REIT (CTRE) to Sector Perform
- Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
